ENTA logo

ENTA
Enanta Pharmaceuticals Inc

1,170
Mkt Cap
$414.76M
Volume
254,763.00
52W High
$15.34
52W Low
$4.09
PE Ratio
-3.68
ENTA Fundamentals
Price
$14.14
Prev Close
$14.37
Open
$14.38
50D MA
$12.00
Beta
1.05
Avg. Volume
314,629.89
EPS (Annual)
-$3.84
P/B
4.67
Rev/Employee
$544,366.67
Loading...
Loading...
News
all
press releases
Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Scott Rottinghaus Sells 798 Shares
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Scott Rottinghaus sold 798 shares of Enanta Pharmaceuticals stock in a transaction that occurred on Friday, December 5th. The...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Insider Selling: Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Sells 1,394 Shares of Stock
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Brendan Luu sold 1,394 shares of the company's stock in a transaction dated Friday, December 5th. The shares were sold at an...
MarketBeat·5d ago
News Placeholder
Tara Lynn Kieffer Sells 2,106 Shares of Enanta Pharmaceuticals (NASDAQ:ENTA) Stock
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Tara Lynn Kieffer sold 2,106 shares of the firm's stock in a transaction on Friday, December 5th. The stock was sold at an average...
MarketBeat·5d ago
News Placeholder
Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Sells $34,009.70 in Stock
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Yat Sun Or sold 2,390 shares of Enanta Pharmaceuticals stock in a transaction that occurred on Friday, December 5th. The shares...
MarketBeat·5d ago
News Placeholder
Enanta Pharmaceuticals (NASDAQ:ENTA) CEO Jay Luly Sells 4,743 Shares of Stock
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) CEO Jay Luly sold 4,743 shares of the business's stock in a transaction on Friday, December 5th. The stock was sold at an average price of...
MarketBeat·5d ago
News Placeholder
Insider Selling: Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Sells 798 Shares of Stock
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Scott Rottinghaus sold 798 shares of the firm's stock in a transaction dated Friday, December 5th. The shares were sold at an...
MarketBeat·6d ago
News Placeholder
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) have received a consensus rating of "Moderate Buy" from the seven ratings firms that are covering the company, MarketBeat.com...
MarketBeat·12d ago
News Placeholder
Enanta Pharmaceuticals (ENTA) Projected to Post Earnings on Monday
Enanta Pharmaceuticals (NASDAQ:ENTA) will be releasing its Q4 2025 earnings before the market opens on Monday, December 1. (View Earnings Report at...
MarketBeat·18d ago
News Placeholder
Research Analysts Set Expectations for ENTA Q1 Earnings
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Free Report) - HC Wainwright issued their Q1 2026 earnings estimates for shares of Enanta Pharmaceuticals in a research report issued to clients and...
MarketBeat·20d ago
News Placeholder
Equities Analysts Set Expectations for ENTA FY2030 Earnings
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Free Report) - Investment analysts at HC Wainwright issued their FY2030 earnings per share estimates for shares of Enanta Pharmaceuticals in a note issued...
MarketBeat·21d ago

Latest ENTA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.